Skip to content
Altius – Lifestyle
Author:
Tangram Therapeutics PLC
Tangram Therapeutics Announces Progression to Patient Cohorts in Phase 1/2 RESTORE-MASH Trial of TGM-312 and Appointment of Dr Sonya Montgomery as Chief Development Officer
September 3, 2026
Arthur J. Gallagher & Co. Announces First Quarter 2026 Financial Results
May 12, 2026